By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — A common virus once thought harmless to ...

NFL legend Brett Favre is once again making headlines, but this time it’s not for a comeback or a sports scandal—it’s for his unconventional approach to fighting Parkinson’s disease.

NFL legend Brett Favre is once again making headlines, but this time it’s not for a comeback or a sports scandal—it’s for his unconventional approach to fighting Parkinson’s disease. After ...

Morgan Wallen's entrances have become a regularly-occurring tradition for the country music superstar. And on Sunday, he was ...

Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues.

“We’re the Jiggle Wiggle Crew,” said Ryan’s older brother, Shawn, as the two show their team T-shirt for the upcoming Parkinson’s Foundation Moving Day Tampa Bay fundraising walk.

Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease Business Wire Jun 15, 2025 ...

Cite this: Understanding the Molecular Basis of Parkinson's Disease, Identification of Biomarkers and Routes to Therapy - Medscape - Aug 01, 2010.

The single-center, open-label Phase 2a study evaluated a 40mg oral daily dose of VTX3232 in ten patients with early-stage, idiopathic Parkinson’s disease over a 28-day treatment period.